Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1968934rdf:typepubmed:Citationlld:pubmed
pubmed-article:1968934lifeskim:mentionsumls-concept:C0229664lld:lifeskim
pubmed-article:1968934lifeskim:mentionsumls-concept:C0552764lld:lifeskim
pubmed-article:1968934lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:1968934lifeskim:mentionsumls-concept:C0150312lld:lifeskim
pubmed-article:1968934lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:1968934lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:1968934pubmed:issue3lld:pubmed
pubmed-article:1968934pubmed:dateCreated1990-4-16lld:pubmed
pubmed-article:1968934pubmed:abstractTextThe proliferative response of peripheral blood T cells to hepatitis B core antigen (HBcAg) was studied in hepatitis B patients. CD4+ T cells from patients with chronic active hepatitis type B (CAH-B) exhibited a significant proliferative response to HBcAg, especially in hepatitis B envelope antigen (HBeAg)-positive patients. In contrast, there was no apparent T cell reaction to HBcAg in patients with CAH non-A, non-B, HBeAg-positive healthy carriers and in healthy volunteers. The proliferative response to CD4+ cells to bacterial extracts of Escherichia coli was always insignificant in all patients and healthy volunteers. The CD8+ cells did not proliferate in response to HBcAg in any subject, even in the presence of autologous irradiated CD4+ responder cells. The CD8+ cells, preactivated with HBcAg and HBcAg-reactive irradiated autologous CD4+ cells, suppressed the proliferative response to autologous CD4+ cells to HBcAg but not the response to phytohemagglutinin in HBcAg-responder CAH-B patients. CD4-mediated HBcAg-specific enhancement and CD8-mediated HBcAg-specific suppression in the peripheral blood compartments of HBcAg-responsive CAH-B patients are possible.lld:pubmed
pubmed-article:1968934pubmed:languageenglld:pubmed
pubmed-article:1968934pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1968934pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1968934pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1968934pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1968934pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1968934pubmed:statusMEDLINElld:pubmed
pubmed-article:1968934pubmed:monthMarlld:pubmed
pubmed-article:1968934pubmed:issn0022-1899lld:pubmed
pubmed-article:1968934pubmed:authorpubmed-author:WatanabeSSlld:pubmed
pubmed-article:1968934pubmed:authorpubmed-author:ShiraiMMlld:pubmed
pubmed-article:1968934pubmed:authorpubmed-author:NishiokaMMlld:pubmed
pubmed-article:1968934pubmed:authorpubmed-author:HanadaHHlld:pubmed
pubmed-article:1968934pubmed:authorpubmed-author:KurokouchiKKlld:pubmed
pubmed-article:1968934pubmed:issnTypePrintlld:pubmed
pubmed-article:1968934pubmed:volume161lld:pubmed
pubmed-article:1968934pubmed:ownerNLMlld:pubmed
pubmed-article:1968934pubmed:authorsCompleteYlld:pubmed
pubmed-article:1968934pubmed:pagination420-5lld:pubmed
pubmed-article:1968934pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:meshHeadingpubmed-meshheading:1968934-...lld:pubmed
pubmed-article:1968934pubmed:year1990lld:pubmed
pubmed-article:1968934pubmed:articleTitlePeripheral blood CD4-mediated enhancement and CD8-mediated suppression in the presence of recombinant hepatitis B virus core antigen.lld:pubmed
pubmed-article:1968934pubmed:affiliationThird Department of Internal Medicine, Kagawa Medical School, Japan.lld:pubmed
pubmed-article:1968934pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1968934pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed